Gilad Itchaki

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Leukemia & lymphoma

Clinical rheumatology

Blood advances

British journal of haematology

Rabin Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rabin Medical Center

Israel

Associate physician :: Institute of Hematology

Dana Farber Cancer Institute Sep 01 2016 - Sep 01 2018

United States

Advanced fellowship in CLL/lymphoma :: Medical Oncology

Rabin Medical Center

Israel

Attending physician :: Institute of Hematology

Rabin Medical Center

Israel

Hematology fellowship :: Institute of Hematology

Rabin Medical Center

Israel

Residency :: Internal Medicine

Rabin Medical Center

Israel

Internship

Publications

Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar I Abdel-Wahab, Mariko Yabe, Young Rock Chung, Gilad Itchaki, Maayan Ben-Sasson, Vered A Asher-Guz, David Groshar, Seyram A Doe-Tetteh, Tina Alano, David B Solit, Ofer Shpilberg, Eli L Diamond, Roei David Mazor
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms. Blood advances (2023)
Sara Steffanoni, Teresa Calimeri, Alice Laurenge, Christopher Paul Fox, Carole Soussain, Christian Grommes, Maria Chiara Tisi, Jesca Boot, Nicola Crosbie, Carlo Visco, Luca Arcaini, Sridhar Chaganti, Marianna C Sassone, Alvaro Alencar, Daniele Armiento, Ilaria Romano, Jorg Dietrich, Gilad Itchaki, Riccardo Bruna, Nicola S Fracchiolla, Laura Arletti, Adriano Venditti, Stephen W Booth, Pellegrino Musto, Khê Hoang Xuan, Tracy T Batchelor, Kate Cwynarski, Andrés José Maria Ferreri
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group. British journal of haematology 199 (4) (2022)
Inbar Nardi Agmon, Ashraf Hamdan, Alon Eisen, Katia Orvin, Avital Porter, Hana Vaknin-Assa, Gilad Itchaki, Yair Molad, Ran Kornowski, Osnat Itzhaki Ben Zadok
Diffused coronary involvement in Takayasu arteritis with concomitant malignancy. Clinical rheumatology (2021)
Shai Shimony, Einat Bar-Sever, Tamar Berger, Gilad Itchaki, Ronit Gurion, Moshe Yeshurun, Meir Lahav, Pia Raanani, Ofir Wolach
Late onset neutropenia after rituximab and obinutuzumab treatment - characteristics of a class-effect toxicity. Leukemia & lymphoma 62 (12) (2021)
Ilana Levy Yurkovski, Avital Lavi, Eran Zimran, Sigal Grisariu, Shlomzion Aumann, Gilad Itchaki, Tamar Berger, Pia Raanani, Reut Harel, Ariel Aviv, Noa Lavi, Tsila Zukerman, Lev Shvidel, Osnat Jarchowsky, Martin Ellis, Katrin Herzog Tzarfati, Maya Koren-Michowitz, Yehonatan Sherf, Itai Levi, Orit Sofer, Ofer Shpilberg, Nagib Dally, Celia Suriu, Andrei Braester, Sharon Ben Barouch, Merav Leiba, Daniela Goldstein, Nadav Sarid, Shay Yeganeh, Jabour Halloun, Moshe Mittelman, Tamar Tadmor
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leukemia & lymphoma (2021)
Jorge J Castillo, Gilad Itchaki, Joshua N Gustine, Kirsten Meid, Catherine A Flynn, Maria G Demos, Maria L Guerrera, Cristina Jimenez, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J Patterson, Lian Xu, Guang Yang, Zachary R Hunter, Steven P Treon
A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia. Leukemia & lymphoma 61 (6) (2020)

Gilad Itchaki.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gilad Itchaki